133 related articles for article (PubMed ID: 38541302)
1. Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
Costa AS; Baracat EC; Júnior JMS; Sorpreso ICE
Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541302
[TBL] [Abstract][Full Text] [Related]
2. [Trends and inequalities in self-reported cervical cancer screening in Brazilian capitals from 2011 to 2020].
Vieira YP; Viero VDSF; Vargas BL; Nunes GO; Machado KP; Neves RG; Saes MO
Cad Saude Publica; 2022; 38(9):e00272921. PubMed ID: 36287397
[TBL] [Abstract][Full Text] [Related]
3. [Colon and rectal cancer mortality in Brazilian capitals, 1980-1997].
das Neves FJ; Mattos IE; Koifman RJ
Arq Gastroenterol; 2005; 42(1):63-70. PubMed ID: 15976914
[TBL] [Abstract][Full Text] [Related]
4. Patterns of hospital utilization in the Unified Health System in six Brazilian capitals: comparison between the year before and the first six first months of the COVID-19 pandemic.
Portela MC; de Aguiar Pereira CC; Lima SML; de Andrade CLT; Martins M
BMC Health Serv Res; 2021 Sep; 21(1):976. PubMed ID: 34535135
[TBL] [Abstract][Full Text] [Related]
5. [Human Development Index and secondary prevention of breast and cervical cancer: an ecological study].
Sadovsky AD; Poton WL; Reis-Santos B; Barcelos MR; Silva IC
Cad Saude Publica; 2015 Jul; 31(7):1539-50. PubMed ID: 26248108
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 Pandemic on Cervical Cancer Screening in São Paulo State, Brazil.
Martins TR; Witkin SS; Mendes-Corrêa MC; Godoy AS; Cury L; Balancin ML; Ab'Saber AM; Peres SV; Messias S; Tozetto Mendoza TR; Longatto-Filho A
Acta Cytol; 2023; 67(4):388-394. PubMed ID: 36682351
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of cervical cancer control actions within Brazil and its regions based on data recorded in the Brazilian Unified National Health System].
Silva GAE; Alcantara LLM; Tomazelli JG; Ribeiro CM; Girianelli VR; Santos ÉC; Claro IB; Almeida PF; Lima LD
Cad Saude Publica; 2022; 38(7):e00041722. PubMed ID: 35894365
[TBL] [Abstract][Full Text] [Related]
8. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
9. Inequalities in mammography and Papanicolaou test coverage: a time-series study.
Malta DC; Prates EJS; Silva AGD; Santos FMD; Oliveira GC; Vasconcelos NM; Cristo EB
Sao Paulo Med J; 2020; 138(6):475-482. PubMed ID: 33111921
[TBL] [Abstract][Full Text] [Related]
10. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602
[TBL] [Abstract][Full Text] [Related]
11. Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
Ferreira HNC; Capistrano GN; Morais TNB; Costa KTDS; Quirino ALS; Costa RLPD; Andrade FB
PLoS One; 2023; 18(10):e0278011. PubMed ID: 37883452
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic and regional inequalities of pap smear coverage.
Manica ST; Drachler Mde L; Teixeira LB; Ferla AA; Gouveia HG; Anschau F; Oliveira DL
Rev Gaucha Enferm; 2016 Mar; 37(1):e52287. PubMed ID: 26982680
[TBL] [Abstract][Full Text] [Related]
14. Impact of the program life in traffic and new zero-tolerance drinking and driving law on the prevalence of driving after alcohol abuse in Brazilian capitals: An interrupted time series analysis.
Guimarães RA; de Morais Neto OL; Dos Santos TMB; Mandacarú PMP; Machado EL; Caiaffa WT; Filho PRP; Aquino ÉC; Reisen VA
PLoS One; 2023; 18(10):e0288288. PubMed ID: 37862323
[TBL] [Abstract][Full Text] [Related]
15. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.
Demarteau N; Breuer T; Standaert B
Pharmacoeconomics; 2012 Apr; 30(4):337-53. PubMed ID: 22409292
[TBL] [Abstract][Full Text] [Related]
16. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
BMC Cancer; 2018 Feb; 18(1):126. PubMed ID: 29394915
[TBL] [Abstract][Full Text] [Related]
17. Cervical Cancer Screening-Past, Present, and Future.
Wentzensen N; Clarke MA
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):432-434. PubMed ID: 33857013
[TBL] [Abstract][Full Text] [Related]
18. In-hospital case fatality ratio due to COVID-19 in four Brazilian state capitals and its possible temporal relationship with the Gamma variant, 2020-2021.
Orellana JDY; Marrero L; Horta BL
Epidemiol Serv Saude; 2021; 30(4):e2021709. PubMed ID: 34852130
[TBL] [Abstract][Full Text] [Related]
19. Convergence in alcohol abuse in Brazilian capitals between genders, 2006 to 2019: what population surveys show.
Malta DC; Silva AGD; Prates EJS; Alves FTA; Cristo EB; Machado ÍE
Rev Bras Epidemiol; 2021; 24(suppl 1):e210022. PubMed ID: 33886895
[TBL] [Abstract][Full Text] [Related]
20. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
